Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens

Georgi Momekov, Denitsa Momekova
doi: https://doi.org/10.1101/2020.04.11.20061804

Data Availability

The manuscript is based on survey of pharmacokinetic and virological data available in the published literature.

Back to top
Posted May 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens
Georgi Momekov, Denitsa Momekova
medRxiv 2020.04.11.20061804; doi: https://doi.org/10.1101/2020.04.11.20061804
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area